Original language | English |
---|---|
Pages (from-to) | e241-e243 |
Journal | The Lancet Rheumatology |
Volume | 3 |
Issue number | 4 |
DOIs |
|
Publication status | Published - 1 Apr 2021 |
Perspective of patients with autoimmune diseases on COVID-19 vaccination
Laura Boekel, Femke Hooijberg, Zoé L. E. van Kempen, Erik H. Vogelzang, Sander W. Tas, Joep Killestein, Michael T. Nurmohamed, Maarten Boers, Taco W. Kuijpers, S. Marieke van Ham, Filip Eftimov, Luuk Wieske, Theo Rispens, Gertjan J. Wolbink
- Rheumatology (VUmc)
- AII - Inflammatory diseases (VUmc)
- APH - Societal Participation & Health (VUmc)
- Neurology (VUmc)
- Amsterdam Neuroscience - Neuroinfection & -inflammation (VUmc)
- Medical Microbiology and Infection Prevention (VUmc)
- ACS - Atherosclerosis & ischemic syndromes (VUmc)
- Epidemiology and Data Science (VUmc)
- APH - Methodology (VUmc)
- Experimental Immunology (AMC)
- Clinical Immunology and Rheumatology (AMC)
- AII - Inflammatory diseases (AMC)
- Landsteiner Laboratory (AMC)
- Paediatric Infectious Diseases / Rheumatology / Immunology (AMC)
- AR&D - Amsterdam Reproduction & Development
- Neurology (AMC)
- Amsterdam Neuroscience - Neuroinfection & -inflammation (AMC)
- EURO-NMD
Research output: Contribution to journal › Comment/Letter to the editor › Academic
68
Citations
(Scopus)